This study investigated the association between infectious microbes and persistent infection with human papillomavirus type 16 (HPV-16) in cervical cancer. Bacterial strains (identified as Enterococcus, Staphylococcus, Bacillus and Corynebacterium, based on their partial 16S rDNA sequence) were HPV-16 positive from 12 out of 14 cervical cancer biopsies. Total DNA was isolated from the four bacterial strains, and HPV-16 genes and genome were detected using polymerase chain reaction (PCR) and Southern blotting. RNA transcripts for HPV-16 E6 and L1 genes were detected in total bacterial RNA samples using reverse transcription-PCR, and HPV-16 L1 protein expression was detected in bacterial cells by Western blotting and immunocolloidal gold electron microscopy. The presence of virus particles in bacterial cells was demonstrated by transmission electron microscopy. The results suggest that bacteria carrying HPV-16 could provide a potential explanation for how infectious microbes contribute to the progression from HPV-16 infection to cervical cancer.
WalboomersJMJacobsMVManosMM: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol1999; 189: 12–19.
2.
HoGYBiermanRBeardsleyL: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med1998; 338: 423–428.
3.
SellorsJWKarwalajtysTLKaczorowskiJ: Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ2003; 168: 421–425.
4.
CastlePEHillierSLRabeLK: An association of cervical inflammation with highgrade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev2001; 10: 1021–1027.
5.
JonesCJBrintonLAHammanRF: Risk factors for in situ cervical cancer: Results from a case-control study. Cancer Res1990; 50: 3657–3662.
6.
MaZHZhangFCMeiXD: Mutations of human papillomavirus (HPV) 16 type L1 genes from cervical carcinoma biopsies in southern Xinjiang Uygur women. Zhonghua Yi Xue Za Zhi2004; 84: 987–991 [in Chinese].
7.
MaCLLiYJZhangFC: Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction. Zhonghua Yi Xue Za Zhi2004; 84: 469–473 [in Chinese].
8.
XuLLiuLHLiYJ: Study on the expression level of XinJiang strain HPV-16 L1 in eukaryotic cells. Chin J Cell Biol2008; 30: 499–503 [in Chinese].
9.
EngvallEOPetterssonBPerssonM: A 16S rRNA-based PCR assay for detection and identification of granulocytic Ehrlichia species in dogs, horses, and cattle. J Clin Microbiol1996; 34: 2170–2174.
10.
HirtB: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol1967; 26: 365–369.
11.
ZhaoKNFrazerIH: Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions. J Virol2002; 76: 3359–3364.
12.
SeedorfKKrammerGDurstM: Human papillomavrius type 16 DNA sequence. Virology1985; 145: 181–185.
13.
HudelistGManaviMPischingerKI: Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: Different levels of viral integration are correlated with lesion grade. Gynecol Oncol2004; 92: 873–880.
14.
CliffordGMSmithJSAguadoT: Comparison of HPV type distribution in highgrade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer2003; 89: 101–105.
15.
BoschFXManosMMMunozN: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst1995; 87: 796–802.
16.
zur HausenH: Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer2002; 2: 342–350.
17.
AngelettiPCKimKFernandesFJ: Stable replication of papillomavirus genomes in Saccharomyces cerevisiae. J Virol2002; 76: 3350–3358.
18.
ZhaoKNFrazerIH: Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol2002; 76: 12265–12273.
19.
KalantariMBlennowEHagmarB: Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol2001; 10: 46–54.
20.
DurstMCroceCMGissmannL: Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA1987; 84: 1070–1074.
21.
Arias-PulidoHPeytonCLJosteNE: Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol2006; 44: 1755–1762.
22.
BrintonLAHammanRFHugginsGR: Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst1987; 79: 23–30.
23.
DelvesPJRoittIM: The immune system. First of two parts. N Engl J Med2000; 343: 37–49.
24.
ReidG: Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr2001; 73 (2 suppl): 437S–443S.
25.
ReidGSeidenfeldA: Drug resistance amongst uropathogens isolated from women in a suburban population: Laboratory findings over 7 years. Can J Urol1997; 4: 432–437.
26.
CorbishleyCM: Microbial flora of the vagina and cervix. J Clin Pathol1977; 30: 745–748.
27.
Von GruenigenVEColemanRLLiAJ: Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patients. Obstet Gynecol2000; 96: 23–27.
28.
BrookIBarrettCTBrinkmanCR: Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: A prospective study. Pediatrics1979; 63: 451–455.
29.
WinerRLLeeSKHughesJP: Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol2003; 157: 218–226.
30.
RintalaMAGrenmanSEPuranenMH: Transmission of high-risk human papillomavirus (HPV) between parents and infant: A prospective study of HPV in families in Finland. J Clin Microbiol2005; 43: 376–381.
31.
BurchellANRichardsonHMahmudSM: Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol2006; 163: 534–543.
